RADX

0.63046.33%
RC

Riccardo Canevari

MD, CEO & Director

Mr. Riccardo Canevari is Managing Director & Chief Executive Officer at Radiopharm Theranostics Limited since September 13, 2021 and is its Director since 2021. He was Chief Commercial Officer of Advanced Accelerator Applications S.A. from April 2020 to September 2021. He was Senior Vice President & Global Head, Breast Cancer Franchise, for Novartis Oncology since 2017. As Franchise Head, he led global strategy and execution in the top nine markets for the global breast cancer franchise. He was also responsible for overseeing the launch of major breast cancer products, including KISQALI and PIQRAY. From 2013 to 2017, he served as General Manager and Country President Greece for Novartis Pharma. In this role, he oversaw 500 associates in five business franchises. During this period, he maintained business continuity during a major financial crisis in Greece, achieving a best-in-class market penetration despite a volatile economic environment. Prior to this, he was General Manager and Cluster Head for Novartis Pharma. From 2005 to 2011, he served in country Business Head and Sales Force Head roles in Italy for Novartis Pharma and Ethicon, a Johnson & Johnson company. Before this, he held several Brand Manager positions with increasing responsibility at the Menarini Group, Novartis Pharma and Novartis Oncology. He holds a University degree in Pharmacy, Chemistry and Pharmaceutical Technologies from University of Pavia, Italy. He has also completed Executive Education coursework in marketing, finance, general management and leadership from the Wharton School of the University of Pennsylvania, Columbia Business School and Harvard Business School.

Positions